Non-NPV-exercise group | NPV-exercise group | |||
---|---|---|---|---|
Baseline | 12 weeks | Baseline | 12 weeks | |
FVC, % predicted | ||||
ILD | 40.3 ± 10.3 | 38.4 ± 13.5 | 36.3 ± 13.0 | 40.5 ± 11.6b, c |
Chest wall | 32.7 ± 8.6 | 37.0 ± 14.5 | 28.0 ± 8.5 | 28.3 ± 7.4 |
FEV1, % predicted | ||||
ILD | 45.6 ± 11.8 | 43.8 ± 18.2 | 40.9 ± 15.8 | 45.9 ± 15.2a |
Chest wall | 35.3 ±11.3 | 44.2 ± 20.2 | 31.9 ± 8.6 | 33.3 ± 8.0 |
FEV1/FVC, % | ||||
ILD | 81.8 ± 6.8 | 84.4 ±7.9 | 82.3 ± 9.7 | 81.0 ±11.8 |
Chest wall | 88.8 ± 10.6 | 82.2 ± 8.1 | 83.8 ± 9.7 | 86.6 ± 9.1 |
6MWD, m | ||||
ILD | 385.2 ± 82.6 | 355.3 ± 85.0 | 352.3 ± 52.8 | 399.5 ± 45.1a |
Chest wall | 318.2 ± 122.4 | 288.0 ± 99.3 | 395.0 ± 99.9 | 412.8 ± 109.8 |
SaO2, % pre/post 6MWT | ||||
ILD | 94.3/ 78.7 | 93.1/ 78.6 | 96.0/80.5 | 96.3/83.1 |
Chest wall | 94.8/ 77.3 | 93.3/ 73.3 | 91.3/72.6 | 92.4/74.1 |
Borg, pre/ post 6MWT | ||||
ILD | 0.9/ 5.1 | 1.5/5.8 | 1.7/ 5.5 | 0.8/4.8 |
Chest wall | 2.0/ 5.8 | 1.7/5.8 | 1.1/ 5.3 | 0.8/5.0 |
SGRQ | ||||
Symptom score | ||||
ILD | 47.6 ± 21.5c | 42.1 ± 19.3c | 61.7 ± 16.6e | 29.5 ± 19b,e |
Chest wall | 50.3 ± 5.8d | 64.1 ± 0.2d | 53.7 ± 5.8f | 45.9 ± 5.6a,f |
Active score | ||||
ILD | 62.2 ± 21.5 | 73.7 ± 12.8 | 61.4 ± 27.4 | 53.5 ± 23.2 |
Chest wall | 59.5 ± 0.0 | 66.4 ± 18.8 | 43.9 ± 17.6 | 36.5 ± 22.0 |
Impacts score | ||||
ILD | 29.3 ± 13.6 | 43.9 ± 19.2 | 48.3 ± 25.3 | 30.0 ± 25.3a |
Chest wall | 32.9 ± 16.7 | 58.0 ± 38.9 | 21.2 ± 11.7 | 13.5 ± 12.2 |
Total score | ||||
ILD | 42.3 ± 16.0 | 52.6 ± 14.0 | 54.5 ± 21.3 | 37.0 ± 21.1a |
Chest wall | 43.8 ± 9.8 | 61.6 ± 26.4 | 32.2 ± 10.0 | 21.3 ± 11.5a |